NCT03899467 2024-02-12
The Safety and Tolerability of GT0918 in Subjects With mHSPC and mCRPC
Suzhou Kintor Pharmaceutical Inc,
Phase 2 Completed
Clinical Trials
1 trialsPhase 2 × Metastatic Castrate Resistant Prostate Cancer (mCRPC) × Androgen Receptor Antagonists × Clear all